Martingale Asset Management »

Aura Biosciences shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $506k 71k 7.10
2023-09-30 $221k 25k 8.97
2023-06-30 $305k 25k 12.35
2023-03-31 $189k 20k 9.28

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding Aura Biosciences

TCG Crossover Management
Suvretta Capital Management
Frazier Life Sciences Management
Long Focus Capital Management
BlackRock
Adage Capital Partners GP
Caligan Partners
Vanguard Capital Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Medicxi Ventures Management
Nantahala Capital Management
Jupiter Topco
RA Capital Management
Balyasny Asset Management

View all funds holding Aura Biosciences